Skip to main content
FinSpry Logo
FinSpry
ROIV logo
ROIV
(NASDAQ)
Roivant Sciences Ltd.
$32.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Roivant Sciences (ROIV) Stock Price & Financial Analysis

Roivant Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$30.57 - $32.11
52-Week High$32.79
52-Week Low$10.71
Open$31.74
Volume8.26M
Average Volume (3M)6.23M
Market Cap21.81B
Shares Outstanding693.86M
Price to Sales (P/S)2640.21
Price to Book (P/B)4.82
EV/EBITDA-48.32
Revenue (TTM)8.26M
Net Income (TTM)-299.77M
Free Cash Flow (TTM)-758.56M
EPS (TTM)$-0.42
Profit Margin-3629.19%
Operating Margin-15560.57%
Return on Equity (ROE)-6.62%
Debt to Equity0.02
50-Day MA$29.13
200-Day MA$23.56
52-Week Change174.74%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Roivant Sciences

What is the current stock price for ROIV?

As of the latest trading session, ROIV stock trades at $31.43. The 52-week range is $10.71–$32.79, with a day range of $30.57–$32.11.

What is the P/E ratio for ROIV?

The P/E ratio (Price-to-Earnings) for ROIV is shown in the Key Statistics section. This valuation metric helps compare Roivant Sciences Ltd. to industry peers.

Does ROIV pay dividends?

Roivant Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ROIV?

Based on 10 analysts, the consensus for ROIV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ROIV?

Roivant Sciences's market capitalization is $21.81B, classifying it as a large-cap company. Roivant Sciences operates in the Healthcare sector within the Biotechnology industry.